Abstract
An association between sarcoidosis and lymphoproliferative diseases (LD), the sarcoidosis-lymphoma syndrome, has been previously described, and may be attributed to the underlying immunological abnormalities that occur during the sarcoidosis disease process.
We report two patients who developed Hodgkin’s disease and diffuse large B-cell non-Hodgkin’s lymphoma (NHL) subsequent to their diagnosis of sarcoidosis after latency periods of 6 years and 18 years respectively. Both patients developed histologically-proven sarcoidosis late in life, at 46 years and 58 years, and had differing clinical courses. The first had radiographically staged II chronic progressive respiratory sarcoidosis (RS) and required long-term methotrexate to control the disease, while the second achieved a spontaneous remission of her stage I intrathoracic RS. After treatment, the patient with Hodgkin’s disease remains in remission 2.5 years following six cycles of ABVD protocol chemotherapy and involved-field radiotherapy, while the NHL patient remains in remission at 3 years following six cycles of R-COP protocol chemotherapy.
Clinicians should be aware of the potential risks of malignancy, and especially of LD in sarcoidosis patients. They should be alerted to the possibility of additional pathology by any atypical clinical features, and should biopsy new lesions and adenopathy to exclude any coexistent neoplasm.
Similar content being viewed by others
References
Brincker H, Wilbek E The incidence of malignant tumors in patients with respiratory sarcoidosis. Br J Cancer (1974);29:247–51.
Suen JS, Forse MS, Hyland RH, Chan CK The malignancy-sarcoidosis syndrome. Chest (1990);989:1300–2.
Karakantza M et al Association between sarcoidosis and lymphoma. J Clin Pathol (1996);49:208–12.
Brincker H The sarcoidosis-lymphoma syndrome. Br J Cancer (1986);54:467–73.
Tufan A et al Concurrent presentations of the sarcoidosis, tuberculosis and lymphoma in a single patient. Resp Med (2006);100:951–53.
Merchant TE, Filippa DA, Yahalom J Sarcoidosis following chemotherapy for Hodgkin’s disease. Leuk Lymphoma (1994);13:339–47.
Nakamura Y et al Muscle sarcoidosis following malignant lymphoma: diagnosis by MR imaging. Skeletal Radiol (2002);31:702–5.
Kornacker M, Kraemer A, Leo E, Ho AD Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin’s lymphoma: report of two cases. Ann Hematol (2002);81:103–5.
Marschke RF Sarcoidosis and malignant neoplasm: the Mayo Clinic experience. Sarcoidosis (1986);3:149–150.
Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999);160:1668–72.
Vourlekis JS, Sawyer RT, Newman LS Sarcoidosis: developments in etiology, immunology and therapeutics. Adv Inter Med (2000);45:209–57.
Römer FK, Hommelgaard P, Schou G Sarcoidosis and cancer revisited: a long term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J (1998);12:906–12.
Seersholm N, Vestbo J, Viskum K Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax (1997);52:892–4.
Yamagouchi M et al Excess death of lung cancer among sarcoidosis patients. Sarcoidosis (1991);8:51–5.
Reich JM, Mullooly JP, Johnson RE Linkage analysis of malignancy-associated sarcoidosis. Chest (1995);107:605–13.
Brincker H Sarcoid reactions in malignant tumours. Cancer Treat Rev (1986);13:147–156.
American Thoracic Society. Statement on sarcoidosis. Am J Crit Care Med (1999);160:736–55.
Acknowledgments
We would very much like to thank Dr Henry Dushan Edward Atkinson, Imperial College Medical School, St Mary’s Hospital, Praed Street, London W2 1NY, UK for his critical review and assistance in the writing of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suvajdzic, N., Milenkovic, B., Perunicic, M. et al. Two cases of sarcoidosis-lymphoma syndrome. Med Oncol 24, 469–471 (2007). https://doi.org/10.1007/s12032-007-0026-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-007-0026-8